<DOC>
	<DOCNO>NCT01162603</DOCNO>
	<brief_summary>- Main objective compare ability Latanoprost 0.005 % preservative-added ophthalmic solution versus Tafluprost 0.0015 % preservative-free ophthalmic solution , give day even , reduce 24-hour intraocular pressure ( IOP ) patient primary open angle glaucoma ( POAG ) and/or ocular hypertension ( OHT ) first diagnosis . First efficacy variable difference mean nocturnal IOP value three month treatment : nocturnal IOP define mean value 2AM 6AM measurement . - Secondary objective comparison Latanoprost 0.005 % Tafluprost 0.0015 % ophthalmic solution : - Mean 24-hour IOP value three month treatment - IOP value time-points : 10AM ( ± 1 hour ) , 2PM ( ± 1 hour ) , 6PM ( ± 1 hour ) , 10PM ( ± 1 hour ) , 2AM ( ± 1 hour ) 6AM ( ± 1 hour ) three month treatment</brief_summary>
	<brief_title>Latanoprost Versus Tafluprost : 24-hour Intraocular Pressure ( IOP )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Male female patient &gt; 45 year Damage optic nerve alteration visual field case POAG , defect optic nerve visual field case OHT Untreated IOP &gt; 24 mm Hg &lt; 32 mm Hg least one eye baseline ( 10AM ) central corneal thickness 500 600 μm Negative pregnancy test ( fertile woman ) . Fertile woman attend study must express clear avoid pregnancy study period next three month Informed consent start study Secondary glaucoma ( SturgeWeber syndrome , Neurofibromatosis I , neovascular glaucoma , steroid glaucoma , etc ) Anterior segment anomaly ( cataract , iridocorneal disgenesy , congenital ectropion uvae , etc ) Past ocular surgery , except cataract surgery previous 6 month Corneal abnormality influence IOP measurement ( corneal oedema ) Positive pregnancy test breastfeed woman . No avoid pregnancy study period next three month</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>